Novartis is a global healthcare company that focuses on discovering, developing, and delivering innovative medicines and treatments to improve patient outcomes.

The company operates in two main business segments: prescription medicines and generics, through its Sandoz division.

Novartis is a leader in pharmaceutical research and development, with a diverse portfolio that spans across key therapeutic areas such as oncology, cardiology, immunology, ophthalmology, and neuroscience. The company is known for its innovative treatments in cancer care, including targeted therapies and immuno-oncology drugs. Additionally, Novartis is a significant player in the field of gene therapies, especially in areas like blood disorders and inherited conditions.

Through its Sandoz division, Novartis also produces generic drugs and biosimilars, which are more affordable alternatives to branded medicines. This helps expand access to essential treatments for patients around the world.

Novartis places a strong emphasis on cutting-edge technologies and data-driven approaches, incorporating artificial intelligence and digital solutions into its research and development processes. The company is committed to improving global health, with a focus on addressing unmet medical needs, enhancing quality of life, and providing sustainable solutions to healthcare challenges.

Operating in over 140 countries, Novartis is dedicated to driving innovation and making a positive impact on the lives of patients worldwide.